蛋白质表现市场－全球产业规模、份额、趋势、机会和预测，按表达系统、产品、最终用户、地区和竞争格局划分，2020-2030年预测

全球蛋白质表现市场规模将从2024年的39亿美元成长到2030年的68.3亿美元，复合年增长率达9.80%。蛋白质表现是指在活细胞内将遗传指令转化为功能性蛋白质的复杂生物学机制，是生物学研究、药物发现和生物製药生产的重要方法。市场成长的主要驱动力是全球对用于治疗用途（包括先进疫苗和单株抗体的开发）的重组蛋白的需求不断增长。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球蛋白质表现市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依表现系统（原核生物、哺乳动物细胞、昆虫细胞、酵母菌、其他）
  • 依产品分类（试剂、感受态细胞、表现载体、服务、仪器）
  • 按最终用户划分（製药和生物技术公司、学术研究机构、合约研究机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美蛋白质表现市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲蛋白质表现市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区蛋白质表现市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲蛋白质表现市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美蛋白质表现市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球蛋白质表现市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• New England BioLabs, Inc.
• Promega Corporation
• QIAGEN GmbH
• Takara Bio, Inc.
• Oxford Expression Technologies Ltd
• LGC Genomics Limited

第十六章：策略建议

第17章调查会社について・免责事项

The Global Protein Expression Market will grow from USD 3.90 Billion in 2024 to USD 6.83 Billion by 2030 at a 9.80% CAGR. Protein expression describes the complex biological mechanisms by which genetic instructions are converted into functional proteins within living cells, constituting an essential methodology for biological research, drug discovery, and biopharmaceutical manufacturing. The market's growth is primarily fueled by the increasing global demand for recombinant proteins for therapeutic applications, including the development of advanced vaccines and monoclonal antibodies.

Key Market Drivers

The global protein expression market is significantly influenced by the increasing demand for biologics and protein therapeutics, which directly drives the need for sophisticated protein production capabilities. Biologics, encompassing monoclonal antibodies, advanced vaccines, and gene therapies, offer highly specific and effective treatment options for a broad spectrum of complex diseases. The consistent expansion in the development and manufacturing of these therapeutics mandates efficient and scalable protein expression systems. According to DCAT Value Chain Insights, in 2024, the FDA's Center for Drug Evaluation and Research approved 16 biological therapeutics, representing 32% of new drug approvals, highlighting the sustained output from this critical sector.

Key Market Challenges

The substantial costs associated with advanced expression systems and specialized reagents present a significant impediment to the growth of the global protein expression market. The financial outlay required for procuring, maintaining, and operating these sophisticated technologies, along with the recurring expense of highly specific reagents, creates a notable barrier to entry. This directly constrains smaller research institutions, emerging biotechnology companies, and academic laboratories from fully leveraging protein expression capabilities due to budget limitations, thereby impeding wider adoption across diverse research and industrial settings.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning for Expression Optimization significantly influences the global protein expression market by offering enhanced efficiency and predictive capabilities. These advanced computational methods enable researchers to precisely predict optimal protein expression conditions and design more effective protein constructs, accelerating drug candidate identification. According to a November 2024 report by the Information Technology and Innovation Foundation, AI has the potential to transform drug development, potentially reducing timelines by approximately half. This technological shift facilitates faster cycles and improved success rates in producing complex proteins. For instance, a September 2024 news release from the University of Texas at Austin detailed their team receiving nearly $2.5 million in grant funding for applying AI in protein engineering research for vaccine development.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• New England BioLabs, Inc.
• Promega Corporation
• QIAGEN GmbH
• Takara Bio, Inc.
• Oxford Expression Technologies Ltd
• LGC Genomics Limited

Report Scope:

In this report, the Global Protein Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Expression Market, By Expression System:

• Prokaryotic
• Mammalian Cell
• Insect Cell
• Yeast
• Others

Protein Expression Market, By Product:

• Reagents
• Competent Cells
• Expression Vectors
• Services
• Instruments

Protein Expression Market, By End user:

• Pharmaceutical and Biotechnological Companies
• Academic Research
• Contract research organizations
• Others

Protein Expression Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Protein Expression Market.

Available Customizations:

Global Protein Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Expression Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Expression System (Prokaryotic, Mammalian Cell, Insect Cell, Yeast, Others)
  • 5.2.2. By Product (Reagents, Competent Cells, Expression Vectors, Services, Instruments)
  • 5.2.3. By End user (Pharmaceutical and Biotechnological Companies, Academic Research, Contract research organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Protein Expression Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Expression System
  • 6.2.2. By Product
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Expression Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Expression System
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Protein Expression Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Expression System
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Protein Expression Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Expression System
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By End user

7. Europe Protein Expression Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Expression System
  • 7.2.2. By Product
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Expression Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Expression System
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By End user
  • 7.3.2. France Protein Expression Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Expression System
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Protein Expression Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Expression System
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Protein Expression Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Expression System
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Protein Expression Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Expression System
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By End user

8. Asia Pacific Protein Expression Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Expression System
  • 8.2.2. By Product
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Expression Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Expression System
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By End user
  • 8.3.2. India Protein Expression Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Expression System
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Protein Expression Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Expression System
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Protein Expression Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Expression System
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Protein Expression Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Expression System
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By End user

9. Middle East & Africa Protein Expression Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Expression System
  • 9.2.2. By Product
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Expression Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Expression System
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Protein Expression Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Expression System
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Protein Expression Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Expression System
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By End user

10. South America Protein Expression Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Expression System
  • 10.2.2. By Product
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Expression Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Expression System
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Protein Expression Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Expression System
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Protein Expression Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Expression System
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories, Inc.
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Merck KGaA
• 15.5. New England BioLabs, Inc.
• 15.6. Promega Corporation
• 15.7. QIAGEN GmbH
• 15.8. Takara Bio, Inc.
• 15.9. Oxford Expression Technologies Ltd
• 15.10. LGC Genomics Limited

16. Strategic Recommendations

17. About Us & Disclaimer